MATOSSIAN-ROGERS ARPI has a total of 13 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Canada, China and Cuba. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ARPI MATOSSIAN ROGERS, MATOSSIAN ROGERS ARPI and KANSAI BUNRI SOGO GAKUEN.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | China | 2 | |
#3 | Cuba | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 | |
#6 | United Kingdom | 1 | |
#7 | Hong Kong | 1 | |
#8 | United States | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Matossian-Rogers Arpi | 13 |
Publication | Filing date | Title |
---|---|---|
AU8451798A | Ligands, including antibodies, showing reactivity against endocrine cells |